Home › Chronic-Phase Myeloid Leukemia › Washington
Chronic-Phase Myeloid Leukemia clinical trials in Washington
3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in Washington.
Cities in Washington
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1136, Edmonds
- Ascentage Investigative Site #1135, Issaquah
- Ascentage Investigative Site #1806, Seattle
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Fred Hutchinson Cancer Research Center, Seattle
- MultiCare Health System Institute, Tacoma
- Northwest Medical Specialties, Tacoma
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Jul 20, 2026 · NCT07091019A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT06163430From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.